Higher plasma soluble Receptor for Advanced Glycation End Products (sRAGE) levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study - Nin, J W; Jorsal, A; Ferreira, I (Diabetes, 2010)
, et al.